

Address:

Columbus, OH, USA

  • Follow
  • Follow
Member Area
  • Home
  • News
  • World HTLV Day
  • Guidelines
  • Clinical Trials
  • Publications
  • Meetings
  • About Us
    • About Us
    • Our Team
Outcomes of patients with adult T-cell leukemia/lymphoma at a university and a public cancer center in Brazil

Outcomes of patients with adult T-cell leukemia/lymphoma at a university and a public cancer center in Brazil

by HTLV | Sep 6, 2026 | Publications

Hematol Transfus Cell Ther. 2026 Sep 5;48(4):106520. doi: 10.1016/j.htct.2026.106520. Online ahead of print. ABSTRACT OBJECTIVE: This study aimed to characterize adult T-cell leukemia/lymphoma (ATLL) cases in Brazil, a human T-cell lymphotropic virus type 1 (HTLV-1)...
Outcomes of patients with adult T-cell leukemia/lymphoma at a university and a public cancer center in Brazil

Author Correction: High expression of Rex-orf-I and HBZ mRNAs and bronchiectasis in lung of HTLV-1A/C infected macaques

by HTLV | Sep 4, 2026 | Publications

Nat Commun. 2026 Sep 3;17(1):9455. doi: 10.1038/s41467-026-77329-y. NO ABSTRACT PMID:42693121 | DOI:10.1038/s41467-026-77329-y
Outcomes of patients with adult T-cell leukemia/lymphoma at a university and a public cancer center in Brazil

A novel biomarker signature based on circulating transfer RNA (tRNA) can detect and differentiate HIV-2 infection from HIV-1

by HTLV | Aug 31, 2026 | Publications

J Clin Microbiol. 2026 Aug 31:e0037826. doi: 10.1128/jcm.00378-26. Online ahead of print. ABSTRACT HIV-1 and HIV-2 share transmission and replication characteristics, but require clinical differentiation. HIV-2 exhibits lower viral loads and slower disease...
Outcomes of patients with adult T-cell leukemia/lymphoma at a university and a public cancer center in Brazil

CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients

by HTLV | Aug 29, 2026 | Publications

J Neurovirol. 2026 Aug 29;32(5):41. doi: 10.1007/s13365-026-01333-7. ABSTRACT CRISPR technology is emerging as a promising therapeutic approach for eliminating chronic viral infections, such as herpesviruses and HIV. Here, for the first time, we demonstrate in vitro...
Outcomes of patients with adult T-cell leukemia/lymphoma at a university and a public cancer center in Brazil

Viral seropositivity in a Brazilian cohort of patients with multiple sclerosis: A retrospective descriptive study

by HTLV | Aug 29, 2026 | Publications

J Neurol Sci. 2026 Aug 25;490:126154. doi: 10.1016/j.jns.2026.126154. Online ahead of print. ABSTRACT BACKGROUND: Defining viral serology in multiple sclerosis (MS) patients has become increasingly more relevant, given the potential association between viruses and MS,...
Outcomes of patients with adult T-cell leukemia/lymphoma at a university and a public cancer center in Brazil

Women’s knowledge, attitudes and practices related to mother-to-child transmission of HTLV-1 in Peru

by HTLV | Aug 27, 2026 | Publications

PLOS Glob Public Health. 2026 Aug 27;6(8):e0007103. doi: 10.1371/journal.pgph.0007103. eCollection 2026. ABSTRACT Human T-cell Lymphotropic Virus type 1 (HTLV-1) can be transmitted from mother to child through breastfeeding and increases the risk of mortality and...
Page 4 of 184« First«...23456...102030...»Last »

Categories

  • Clinical Trials (5)
  • Guidelines (7)
  • News (21)
  • Publications (1,102)
  • Uncategorized (27)

Recent Posts

  • Human T-Cell Leukaemia Virus Type 1-Associated Myelopathy in Patients with Rheumatoid Arthritis: A Case Series Highlighting Functional Disability and Diagnostic Challenges October 5, 2026
  • CDC AIDS Project 72: The Prostitute Study October 4, 2026
  • HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next-Generation Therapies October 2, 2026
  • Human T-lymphotropic Virus Type 1 (HTLV-1)-Associated Uveitis Presenting With Frosted Retinal Vasculitis September 30, 2026
  • Neurological Complications of Oncogenic Viruses: Mechanisms, Clinical Manifestations, and Emerging Insights September 30, 2026


Contact

Use our Contact form



Our Location

Columbus, OH, USA



Contact Us

About IRVA

The mission of the International Retrovirology Association (IRVA) is to encourage research in retrovirology, especially the study of human T-lymphotropic virus (HTLV) infections and the associated diseases, to foster collaborations between research groups, provide a platform for critical analysis of new data, and contribute to the dissemination of knowledge about these infections.

Research



Guidelines



Publications



Events



Meetings

IRVA



About Us



Our Team



News

Privacy Policy | Disclaimer

Copyright © 2026 IRVA. All Rights Reserved.
  • Follow
  • Follow